Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 36

1.
2.

Dilemmas of the causality assessment tools in the diagnosis of adverse drug reactions.

Khan LM, Al-Harthi SE, Osman AM, Sattar MA, Ali AS.

Saudi Pharm J. 2016 Jul;24(4):485-93. doi: 10.1016/j.jsps.2015.01.010. Review.

3.

Hospitalization in older patients due to adverse drug reactions -the need for a prediction tool.

Parameswaran Nair N, Chalmers L, Peterson GM, Bereznicki BJ, Castelino RL, Bereznicki LR.

Clin Interv Aging. 2016 May 2;11:497-505. doi: 10.2147/CIA.S99097. Review.

4.

Detection of adverse drug reactions by medication antidote signals and comparison of their sensitivity with common methods of ADR detection.

Khan LM, Al-Harthi SE, Alkreathy HM, Osman AM, Ali AS.

Saudi Pharm J. 2015 Oct;23(5):515-22. doi: 10.1016/j.jsps.2014.10.003.

5.

Perceived barriers to reporting adverse drug events in hospitals: a qualitative study using theoretical domains framework approach.

Mirbaha F, Shalviri G, Yazdizadeh B, Gholami K, Majdzadeh R.

Implement Sci. 2015 Aug 7;10:110. doi: 10.1186/s13012-015-0302-5.

6.

Timolol-induced interstitial lung disease.

Patel H, Wilches LV, Guerrero J.

Respir Med Case Rep. 2015 Mar 2;15:30-2. doi: 10.1016/j.rmcr.2015.02.006.

7.

Exploring Spanish health social media for detecting drug effects.

Segura-Bedmar I, Martínez P, Revert R, Moreno-Schneider J.

BMC Med Inform Decis Mak. 2015;15 Suppl 2:S6. doi: 10.1186/1472-6947-15-S2-S6.

8.

A systematic review of the prevalence and risk factors for adverse drug reactions in the elderly in the acute care setting.

Alhawassi TM, Krass I, Bajorek BV, Pont LG.

Clin Interv Aging. 2014 Dec 1;9:2079-86. doi: 10.2147/CIA.S71178. Review.

9.

Adverse drug reactions reporting culture in Pharmacovigilance Programme of India.

Kalaiselvan V, Prasad T, Bisht A, Singh S, Singh GN.

Indian J Med Res. 2014 Oct;140(4):563-4. No abstract available.

10.

Mortality from adverse drug reactions in adult medical inpatients at four hospitals in South Africa: a cross-sectional survey.

Mouton JP, Mehta U, Parrish AG, Wilson DP, Stewart A, Njuguna CW, Kramer N, Maartens G, Blockman M, Cohen K.

Br J Clin Pharmacol. 2015 Oct;80(4):818-26. doi: 10.1111/bcp.12567.

11.

T3DB: the toxic exposome database.

Wishart D, Arndt D, Pon A, Sajed T, Guo AC, Djoumbou Y, Knox C, Wilson M, Liang Y, Grant J, Liu Y, Goldansaz SA, Rappaport SM.

Nucleic Acids Res. 2015 Jan;43(Database issue):D928-34. doi: 10.1093/nar/gku1004.

12.
13.

Fatal adverse drug reactions: Experience of adverse drug reactions in a tertiary care teaching hospital of North India - A case series.

Tandon VR, Khajuria V, Mahajan A, Gillani Z, Mahajan V, Chandail V.

Indian J Crit Care Med. 2014 May;18(5):315-9. doi: 10.4103/0972-5229.132499.

14.

Development of an adverse drug reaction risk assessment score among hospitalized patients with chronic kidney disease.

Sharif-Askari FS, Syed Sulaiman SA, Saheb Sharif-Askari N, Al Sayed Hussain A.

PLoS One. 2014 Apr 22;9(4):e95991. doi: 10.1371/journal.pone.0095991.

15.

Medication reviews for nursing home residents to reduce mortality and hospitalization: systematic review and meta-analysis.

Wallerstedt SM, Kindblom JM, Nylén K, Samuelsson O, Strandell A.

Br J Clin Pharmacol. 2014 Sep;78(3):488-97. doi: 10.1111/bcp.12351. Review.

16.

Mining patterns of adverse events using aggregated clinical trial results.

Luo Z, Zhang GQ, Xu R.

AMIA Jt Summits Transl Sci Proc. 2013 Mar 18;2013:112-6.

17.

A new approach to identify, classify and count drug-related events.

Bürkle T, Müller F, Patapovas A, Sonst A, Pfistermeister B, Plank-Kiegele B, Dormann H, Maas R.

Br J Clin Pharmacol. 2013 Sep;76 Suppl 1:56-68. doi: 10.1111/bcp.12189.

18.

Prescription peer academic detailing to reduce inappropriate prescribing for older patients: a cluster randomised controlled trial.

Rognstad S, Brekke M, Fetveit A, Dalen I, Straand J.

Br J Gen Pract. 2013 Aug;63(613):e554-62. doi: 10.3399/bjgp13X670688.

19.

Comparative evaluation of different medication safety measures for the emergency department: physicians' usage and acceptance of training, poster, checklist and computerized decision support.

Sedlmayr B, Patapovas A, Kirchner M, Sonst A, Müller F, Pfistermeister B, Plank-Kiegele B, Vogler R, Criegee-Rieck M, Prokosch HU, Dormann H, Maas R, Bürkle T.

BMC Med Inform Decis Mak. 2013 Jul 29;13:79. doi: 10.1186/1472-6947-13-79.

20.

Experiences from consumer reports on psychiatric adverse drug reactions with antidepressant medication: a qualitative study of reports to a consumer association.

Vilhelmsson A, Svensson T, Meeuwisse A, Carlsten A.

BMC Pharmacol Toxicol. 2012 Dec 23;13:19. doi: 10.1186/2050-6511-13-19.

Items per page

Supplemental Content

Support Center